136 related articles for article (PubMed ID: 9731505)
21. Schwann cells express NDF and SMDF/n-ARIA mRNAs, secrete neuregulin, and show constitutive activation of erbB3 receptors: evidence for a neuregulin autocrine loop.
Rosenbaum C; Karyala S; Marchionni MA; Kim HA; Krasnoselsky AL; Happel B; Isaacs I; Brackenbury R; Ratner N
Exp Neurol; 1997 Dec; 148(2):604-15. PubMed ID: 9417836
[TBL] [Abstract][Full Text] [Related]
22. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.
Harari D; Tzahar E; Romano J; Shelly M; Pierce JH; Andrews GC; Yarden Y
Oncogene; 1999 Apr; 18(17):2681-9. PubMed ID: 10348342
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder.
Amsellem-Ouazana D; Bièche I; Tozlu S; Botto H; Debré B; Lidereau R
J Urol; 2006 Mar; 175(3 Pt 1):1127-32. PubMed ID: 16469638
[TBL] [Abstract][Full Text] [Related]
24. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
25. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
27. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
28. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
29. Neuregulin-beta induces expression of an NMDA-receptor subunit.
Ozaki M; Sasner M; Yano R; Lu HS; Buonanno A
Nature; 1997 Dec 18-25; 390(6661):691-4. PubMed ID: 9414162
[TBL] [Abstract][Full Text] [Related]
30. [Neuregulin/ErbB signal transduction pathway in the development of nervous system].
Huang YZ; Mei L
Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):197-203. PubMed ID: 12545789
[TBL] [Abstract][Full Text] [Related]
31. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Cancer Res; 1996 Mar; 56(6):1184-8. PubMed ID: 8640794
[TBL] [Abstract][Full Text] [Related]
32. Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types.
Salsano E; Pollo B; Eoli M; Giordana MT; Finocchiaro G
Neurosci Lett; 2004 Nov; 370(2-3):180-5. PubMed ID: 15488319
[TBL] [Abstract][Full Text] [Related]
33. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
35. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
Zhao W; Shen Y; Ren S
Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
37. High expression of the EGFR in fibroadenomas compared to breast carcinomas.
Zelada-Hedman M; Werer G; Collins P; Bäckdahl M; Perez I; Franco S; Jimenez J; Cruz J; Torroella M; Nordenskjöld M
Anticancer Res; 1994; 14(5A):1679-88. PubMed ID: 7847801
[TBL] [Abstract][Full Text] [Related]
38. Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum.
Ozaki M; Kishigami S; Yano R
Neurosci Res; 1998 Apr; 30(4):351-4. PubMed ID: 9678639
[TBL] [Abstract][Full Text] [Related]
39. Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis.
Stonecypher MS; Chaudhury AR; Byer SJ; Carroll SL
J Neuropathol Exp Neurol; 2006 Feb; 65(2):162-75. PubMed ID: 16462207
[TBL] [Abstract][Full Text] [Related]
40. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
